You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abiraterone%20Acetate%20(ZYTIGA)

Showing 26 - 50 of 1,212
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,

Recruiting
  • NSCLC Harboring NRG1 Fusion
  • Metastatic Castration-resistant Prostate Cancer
  • Afatinib Oral Tablet
  • +3 more
  • Whittier, California
  • +1 more
Dec 20, 2022

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • La Jolla, California
  • +3 more
Sep 1, 2021

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)

Withdrawn
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • (no location specified)
Aug 5, 2021

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022

Prostate Cancer Trial in United States (Zytiga® (Abiraterone Acetate), SoluMatrix™ (Abiraterone Acetate))

Completed
Has Results
  • Prostate Cancer
  • Zytiga® (Abiraterone Acetate)
  • SoluMatrix™ (Abiraterone Acetate)
  • Laguna Hills, California
  • +16 more
Nov 19, 2021

Prostate Cancer Trial in Boston (Abiraterone, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 8, 2021

Salivary Glands Tumors Trial in Milan (Abiraterone acetate)

Completed
  • Salivary Glands Tumors
  • Abiraterone acetate
  • Milan, Lombardy, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Mar 1, 2021

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Beijing, China
  • +35 more
Aug 9, 2022

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2021

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
  • +2 more
Feb 11, 2022

Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
Nov 15, 2020

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Abiraterone Acetate, Gene Polymorphism, Pharmacokinetic Trial in Wuhan (Abiraterone acetate tablets)

Active, not recruiting
  • Abiraterone Acetate
  • +4 more
  • Abiraterone acetate tablets
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Dec 30, 2021

Prostate Cancer Trial in Gyeonggi-do (BR9004, BR9004-1)

Completed
  • Prostate Cancer
  • Gyeonggi-do, Seongnam-si, Korea, Republic of
    CHA Bundang Medical Center, CHA University
Jul 20, 2021

Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial (Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log)

Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Abiraterone Oral Tablet
  • +3 more
  • (no location specified)
Apr 1, 2022

Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
Jan 17, 2023

Prostate Cancer Trial (Neoadjuvant treatment)

Not yet recruiting
  • Prostate Cancer
  • Neoadjuvant treatment
  • (no location specified)
Oct 19, 2022

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • GnRH agonist/antagonist
  • +3 more
  • Los Angeles, California
  • +3 more
Apr 30, 2021